Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

Medically reviewed by Nicholas R. Metrus, MD Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disease. It affects your nerves and muscle tissue and ...

Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

Familial amyotrophic lateral sclerosis (ALS) is an uncommon form of ALS that occurs due to an inherited gene. The disease causes motor neurons to die, which can lead to progressive muscle weakness.

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, with an incidence of 1 or 2 cases per 100,000 persons and a lifetime risk of 1 case per 800 persons.